Antibody capable of binding specifically to Abeta-oligomer, and use thereof
The present inventors successfully produced monoclonal antibodies that are specific to only soluble Abeta oligomers, but do not recognize soluble Abeta monomers, which are physiological molecules. It is found that the antibody is useful as a monoclonal antibody for the diagnosis/treatment of Alzheim...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
13.07.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present inventors successfully produced monoclonal antibodies that are specific to only soluble Abeta oligomers, but do not recognize soluble Abeta monomers, which are physiological molecules. It is found that the antibody is useful as a monoclonal antibody for the diagnosis/treatment of Alzheimer's disease. |
---|---|
Bibliography: | Application Number: CN200980111237 |